Literature DB >> 1884458

Neuronal reuptake of norepinephrine and production of dihydroxyphenylglycol by cardiac sympathetic nerves in the anesthetized dog.

G Eisenhofer1, J J Smolich, H S Cox, M D Esler.   

Abstract

BACKGROUND: Reuptake of norepinephrine by cardiac sympathetic nerves before and during two levels of electrical stimulation of the left ansa subclavia was estimated in anesthetized dogs from the cardiac production of dihydroxyphenylglycol (DHPG), the intraneuronal metabolite of norepinephrine. METHODS AND
RESULTS: The method depended on the effects of neuronal uptake blockade with desipramine on the cardiac production of [3H]DHPG from intravenously infused [3H]norepinephrine. The ratio of the desipramine-induced decrease in the cardiac extraction of [3H]norepinephrine to the production of [3H]DHPG was used to transform the cardiac production of DHPG from recaptured norepinephrine into a rate for norepinephrine reuptake. Cardiac spillover of norepinephrine into plasma increased from 49 +/- 12 to 205 +/- 40 and 451 +/- 118 pmol/min during sympathetic activation. Cardiac DHPG production increased from 108 +/- 18 to 166 +/- 34 and 240 +/- 47 pmol/min. Desipramine decreased resting cardiac DHPG production by 20% and completely blocked the stimulation-induced increase. Thus, most (80%) cardiac DHPG produced at rest was derived from norepinephrine leaking from storage vesicles. This amount remained constant, and that derived from recaptured norepinephrine increased during sympathetic activation. The cardiac extraction of [3H]norepinephrine (126,000 dpm/min) and production of [3H]DHPG (3,790 dpm/min) were decreased by 55-57% after desipramine. Thus, only 3% of the norepinephrine recaptured by cardiac sympathetic nerves appeared in plasma as DHPG. The remainder was sequestered into storage vesicles (more than 94%) or ultimately formed metabolites other than DHPG (less than 3%). Reuptake of norepinephrine by cardiac sympathetic nerves was 1,188 +/- 476 pmol/min and increased in parallel with cardiac norepinephrine spillover to 4,182 +/- 1,982 and 6,594 +/- 2,241 pmol/min during sympathetic stimulation.
CONCLUSIONS: Of the norepinephrine released by cardiac sympathetic nerves, 16-fold more was recaptured than entered plasma. Combined estimation of norepinephrine reuptake and spillover offers an approach to assess the efficiency of neuronal reuptake in disorders of cardiac function.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1884458     DOI: 10.1161/01.cir.84.3.1354

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

1.  Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma.

Authors:  Lucia Martiniova; Susannah Cleary; Edwin W Lai; Dale O Kiesewetter; Jurgen Seidel; Linda F Dawson; Jacqueline K Phillips; David Thomasson; Xiaoyuan Chen; Graeme Eisenhofer; James F Powers; Richard Kvetnansky; Karel Pacak
Journal:  Nucl Med Biol       Date:  2011-09-29       Impact factor: 2.408

2.  Disposition of endogenous adrenaline compared to noradrenaline released by cardiac sympathetic nerves in the anaesthetized dog.

Authors:  G Eisenhofer; J J Smolich; M D Esler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

Review 3.  Human ageing and the sympathoadrenal system.

Authors:  D R Seals; M D Esler
Journal:  J Physiol       Date:  2000-11-01       Impact factor: 5.182

Review 4.  Sympathetic nerve function--assessment by radioisotope dilution analysis.

Authors:  Graeme Eisenhofer
Journal:  Clin Auton Res       Date:  2005-08       Impact factor: 4.435

5.  Optogenetic release of norepinephrine from cardiac sympathetic neurons alters mechanical and electrical function.

Authors:  Anastasia M Wengrowski; Xin Wang; Srinivas Tapa; Nikki Gillum Posnack; David Mendelowitz; Matthew W Kay
Journal:  Cardiovasc Res       Date:  2014-12-16       Impact factor: 10.787

6.  Effects of glucagon-like peptide-1 and sympathetic stimulation on gastric accommodation in humans.

Authors:  C N Andrews; A E Bharucha; M Camilleri; P A Low; B M Seide; D D Burton; K K Nickander; K L Baxter; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2007-09       Impact factor: 3.598

7.  Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans.

Authors:  Adil E Bharucha; Nisha Charkoudian; Christopher N Andrews; Michael Camilleri; David Sletten; Alan R Zinsmeister; Phillip A Low
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-07-02       Impact factor: 3.619

8.  Relationship of cytochrome P450 pharmacogenetics to the effects of yohimbine on gastrointestinal transit and catecholamines in healthy subjects.

Authors:  A E Bharucha; T Skaar; C N Andrews; M Camilleri; S Philips; B Seide; D Burton; K Baxter; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2008-04-16       Impact factor: 3.598

Review 9.  Molecular imaging in heart failure patients.

Authors:  Nagara Tamaki; Yuji Kuge; Keiichiro Yoshinaga
Journal:  Clin Transl Imaging       Date:  2013-10-09

Review 10.  Sympathetic dysfunction in vasovagal syncope and the postural orthostatic tachycardia syndrome.

Authors:  Elisabeth Lambert; Gavin W Lambert
Journal:  Front Physiol       Date:  2014-07-28       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.